Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iterum Therapeutics plc - Ordinary Share (NQ:ITRM)

0.9500 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20
Open 0.9500
Bid (Size) 0.9305 (2)
Ask (Size) 0.9600 (1)
Prev. Close 0.9500
Today's Range 0.9500 - 0.9500
52wk Range 0.8080 - 3.020
Shares Outstanding 13,041,041
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For May 13, 2025
Via Benzinga
A Look Ahead: Iterum Therapeutics's Earnings Forecast
Via Benzinga

Performance

YTD
-48.1%
-48.1%
1 Month
-24.6%
-24.6%
3 Month
-34.9%
-34.9%
6 Month
-52.3%
-52.3%
1 Year
-28.0%
-28.0%

More News

Read More
Top movers in Tuesday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For February 7, 2025
Via Benzinga
A Look at Iterum Therapeutics's Upcoming Earnings Report
Via Benzinga
Iterum Therapeutics's Earnings: A Preview
Via Benzinga
Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday?
Via Benzinga
Topics Economy World Trade
Exposures Interest Rates Tariff
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 14, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q2 2024
Via InvestorPlace
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q1 2024
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 28, 2024
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Iterum Therapeutics Stock Is Trending Today
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Insiders Buying Iterum Therapeutics And 3 Other Stocks Under $3
Via Benzinga
Topics Stocks
Exposures US Equities
Iterum Therapeutics PLC (NASDAQ: ITRM) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network

Frequently Asked Questions

Is Iterum Therapeutics plc - Ordinary Share publicly traded?
Yes, Iterum Therapeutics plc - Ordinary Share is publicly traded.
What exchange does Iterum Therapeutics plc - Ordinary Share trade on?
Iterum Therapeutics plc - Ordinary Share trades on the Nasdaq Stock Market
What is the ticker symbol for Iterum Therapeutics plc - Ordinary Share?
The ticker symbol for Iterum Therapeutics plc - Ordinary Share is ITRM on the Nasdaq Stock Market
What is the current price of Iterum Therapeutics plc - Ordinary Share?
The current price of Iterum Therapeutics plc - Ordinary Share is 0.9500
When was Iterum Therapeutics plc - Ordinary Share last traded?
The last trade of Iterum Therapeutics plc - Ordinary Share was at 06/05/25 04:00 PM ET
What is the market capitalization of Iterum Therapeutics plc - Ordinary Share?
The market capitalization of Iterum Therapeutics plc - Ordinary Share is 12.39M
How many shares of Iterum Therapeutics plc - Ordinary Share are outstanding?
Iterum Therapeutics plc - Ordinary Share has 12M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.